| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $532,515 | 21 | 100 |
Sells | $0 | 0 | 0 |
| Titterton Lewis H jr | director | 6 | $241,348 | 0 | $0 | $241,348 |
| KUMAR AMIT | Chief Executive Officer | 12 | $231,347 | 0 | $0 | $231,347 |
| Baskies Arnold M | director | 2 | $44,200 | 0 | $0 | $44,200 |
| Catelani Michael | President, COO, & CFO | 1 | $15,620 | 0 | $0 | $15,620 |
Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of CAR-T, specifically for ovarian cancer treatment. The company is also engaged in the discovery and development of antiviral drug candidates to combat …
Over the last 12 months, insiders at Anixa Biosciences, Inc. have bought $532,515 and sold $0 worth of Anixa Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Anixa Biosciences, Inc. have bought $300,619 and sold $42,126 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Titterton Lewis H jr (director) — $241,348. KUMAR AMIT (Chief Executive Officer) — $231,347. Baskies Arnold M (director) — $44,200.
The last purchase of 5,000 shares for transaction amount of $15,850 was made by KUMAR AMIT (Chief Executive Officer) on 2026‑10‑30.
| 2026-10-30 | KUMAR AMIT | Chief Executive Officer | 5,000 0.0149% | $3.17 | $15,850 | -3.13% | ||
| 2026-10-23 | Titterton Lewis H jr | director | 8,000 0.0233% | $2.98 | $23,840 | +4.35% | ||
| 2026-10-22 | KUMAR AMIT | Chief Executive Officer | 8,000 0.0225% | $2.72 | $21,760 | +11.06% | ||
| 2026-09-30 | Catelani Michael | President, COO, & CFO | 5,500 0.0157% | $2.84 | $15,620 | -0.34% | ||
| 2026-09-24 | KUMAR AMIT | Chief Executive Officer | 7,000 0.0205% | $2.78 | $19,460 | +4.50% | ||
| 2026-09-24 | Baskies Arnold M | director | 5,000 0.0145% | $2.76 | $13,800 | +4.50% | ||
| 2026-09-23 | Titterton Lewis H jr | director | 49,036 0.141% | $2.69 | $131,907 | +5.45% | ||
| 2026-09-10 | Titterton Lewis H jr | director | 10,000 0.029% | $2.73 | $27,300 | +1.45% | ||
| 2026-09-10 | KUMAR AMIT | Chief Executive Officer | 3,000 0.0088% | $2.75 | $8,250 | +1.45% | ||
| 2026-09-10 | KUMAR AMIT | Chief Executive Officer | 5,000 0.0147% | $2.76 | $13,800 | +1.45% | ||
| 2026-07-31 | KUMAR AMIT | Chief Executive Officer | 5,000 0.0151% | $3.47 | $17,350 | -13.16% | ||
| 2026-07-27 | KUMAR AMIT | Chief Executive Officer | 8,188 0.0237% | $3.41 | $27,944 | -13.15% | ||
| 2026-07-27 | KUMAR AMIT | Chief Executive Officer | 3,188 0.0085% | $3.37 | $10,744 | -13.15% | ||
| 2026-07-24 | KUMAR AMIT | Chief Executive Officer | 3,000 0.0089% | $3.73 | $11,190 | -18.38% | ||
| 2026-07-20 | Titterton Lewis H jr | director | 12,000 0.036% | $3.47 | $41,640 | -11.71% | ||
| 2026-07-20 | KUMAR AMIT | Chief Executive Officer | 5,000 0.0147% | $3.46 | $17,300 | -11.71% | ||
| 2026-07-15 | Titterton Lewis H jr | director | 2,797 0.0077% | $3.28 | $9,174 | -11.57% | ||
| 2026-07-10 | KUMAR AMIT | Chief Executive Officer | 5,000 0.0146% | $3.04 | $15,200 | +1.96% | ||
| 2026-06-16 | Titterton Lewis H jr | director | 2,836 0.0084% | $2.64 | $7,487 | +17.05% | ||
| 2026-06-12 | KUMAR AMIT | Chief Executive Officer | 21,000 0.0625% | $2.50 | $52,500 | +23.48% |
| Titterton Lewis H jr | director | 1054003 3.0319% | $3.22M | 80 | 1 | +5.26% |
| KUMAR AMIT | Chief Executive Officer | 685000 1.9704% | $2.09M | 69 | 1 | +9.52% |
| Baskies Arnold M | director | 140572 0.4044% | $429,447.46 | 14 | 0 | <0.0001% |
| Catelani Michael | President, COO, & CFO | 50000 0.1438% | $152,750.00 | 7 | 0 | +28.99% |
| KRUSOS DENIS A | Chief Executive Officer | 1969880 5.6665% | $6.02M | 1 | 0 | 0% |
| Stender Tisha | Chief Operating Officer | 800000 2.3012% | $2.44M | 1 | 0 | <0.0001% |
| JOHNSON BRUCE F | director | 419119 1.2056% | $1.28M | 68 | 0 | +8.83% |
| LAROUNIS GEORGE P | director | 320000 0.9205% | $977,600.00 | 1 | 0 | 0% |
| Roop John H. | Sr. Vice President-Engineering | 129500 0.3725% | $395,622.50 | 3 | 0 | <0.0001% |
| BERMAN ROBERT ANDREW | President & CEO | 61553 0.1771% | $188,044.42 | 26 | 0 | +9.15% |
| MONAHAN JOHN J | director | 50900 0.1464% | $155,499.50 | 1 | 0 | <0.0001% |
| Gottschalk Emily | director | 45665 0.1314% | $139,506.58 | 3 | 0 | <0.0001% |
| HERMS HENRY P | V.P., Finance & CFO | 22125 0.0636% | $67,591.88 | 1 | 15 | 0% |
| Cavalier David | director | 2000 0.0058% | $6,110.00 | 1 | 0 | <0.0001% |
Anixa Biosciences, Inc. (ANIX) | $5,552,811 | 165 | 5.84% | $106.2M |
$1,701,941 | 56 | 17.58% | $93.09M | |
$4,898,715 | 46 | 40.75% | $114.69M | |
$130,095 | 43 | 45.19% | $111.24M | |
$77,146,704 | 43 | 13.28% | $93.12M |
| Increased Positions | 32 | +45.07% | 854,254 | +15.6% |
| Decreased Positions | 21 | -29.58% | 589,985 | -10.77% |
| New Positions | 13 | New | 490,083 | New |
| Sold Out Positions | 8 | Sold Out | 32,376 | Sold Out |
| Total Postitions | 82 | +15.49% | 6M | +4.83% |
| Vanguard Group Inc | $4,495.00 | 4.31% | 1.42M | +29,436 | +2.11% | 2025-09-30 |
| D.A. Davidson & Co. | $1,941.00 | 1.86% | 614,272 | 0 | 0% | 2025-09-30 |
| Laird Norton Wetherby Trust Company, Llc | $1,887.00 | 1.81% | 597,235 | -20,000 | -3.24% | 2025-09-30 |
| Ubs Group Ag | $1,499.00 | 1.44% | 474,480 | -30,810 | -6.1% | 2025-09-30 |
| Mission Wealth Management, Lp | $1,125.00 | 1.08% | 356,152 | -13,365 | -3.62% | 2025-09-30 |
| Geode Capital Management, Llc | $1,086.00 | 1.04% | 343,644 | +808 | +0.24% | 2025-09-30 |
| Bank Of America Corp /De/ | $676.00 | 0.65% | 213,955 | +3,645 | +1.73% | 2025-09-30 |
| Blackrock, Inc. | $509.00 | 0.49% | 161,022 | +1,554 | +0.97% | 2025-09-30 |
| State Street Corp | $381.00 | 0.37% | 120,500 | 0 | 0% | 2025-09-30 |
| Citadel Advisors Llc | $303.00 | 0.29% | 96,010 | +25,072 | +35.34% | 2025-09-30 |